Furthermore, genetic and pharmacological disruption of IFN-γ signaling has been shown to reduce AHR and airway remodeling in mice (8, 11), implicating Th1 inflammation in functional and structural changes in severe asthma. The gene discussed is IFNG; the disease is asthma.